
|Articles|December 31, 2015
Michael Mauro Discusses Therapy-Free CML Remission
Author(s)Michael Mauro, MD
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Advertisement
Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses cessation of chronic myeloid leukemia (CML) treatment for therapy-free remission.Â
Mauro says patients with CML are often concerned about how long they have to stay on medication.
Advertisement
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Tentative Approval to Generic Olaparib Tablets
2
GU Oncology Trial Logistics: Nursing Insights from Dana-Farber
3
Study Reports 10-Year Outcomes of Focal Therapy for Prostate Cancer
4
Optimizing Multiple Myeloma Care: Insights From a Nursing Expert
5






















































